XKLS:0155's Quick Ratio is ranked better than 88.84% of 215
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.67
vs XKLS:0155: 5.26
Malaysian Genomics Resource Centre Bhd (XKLS:0155) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Malaysian Genomics Resource Centre Bhd Quick Ratio Related Terms
Malaysian Genomics Resource Centre Bhd Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Malaysian Genomics Resource Centre Bhd Quick Ratio Chart
Malaysian Genomics Resource Centre Bhd Annual Data
XKLS:0155 vs TMO, DHR, IDXX: Quick Ratio Comparison
For the Diagnostics & Research subindustry, Malaysian Genomics Resource Centre Bhd's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Malaysian Genomics Resource Centre Bhd Quick Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Malaysian Genomics Resource Centre Bhd's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Malaysian Genomics Resource Centre Bhd's Quick Ratio falls into.
Malaysian Genomics Resource Centre Bhd Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Malaysian Genomics Resource Centre Bhd (XKLS:0155) has a Quick Ratio of 5.26 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Malaysian Genomics Resource Centre Bhd and its competitors. This is 22% above median its historical median of 4.32. Over the past decade, Malaysian Genomics Resource Centre Bhd's Quick Ratio has ranged from 1.21 to 30.70. According to the industry distribution chart, Malaysian Genomics Resource Centre Bhd ranks #24 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 11.2%.
Is Malaysian Genomics Resource Centre Bhd's Quick Ratio too high?
Malaysian Genomics Resource Centre Bhd's current Quick Ratio of 5.26 is 22% above median its 10-year median of 4.32. Over the past 10 years, this metric has ranged from a low of 1.21 to a high of 30.70. The Medical Diagnostics & Research industry median Quick Ratio is 1.67. Malaysian Genomics Resource Centre Bhd's value of 5.26 is 215% above this industry median. Based on the distribution chart, Malaysian Genomics Resource Centre Bhd ranks #24 out of 215 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Malaysian Genomics Resource Centre Bhd has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Malaysian Genomics Resource Centre Bhd's Quick Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Malaysian Genomics Resource Centre Bhd ranks #24 out of 215 companies for Quick Ratio. This places Malaysian Genomics Resource Centre Bhd in the top 11% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.67. Malaysian Genomics Resource Centre Bhd's value of 5.26 is 215% above this benchmark. Historically, Malaysian Genomics Resource Centre Bhd's own Quick Ratio has ranged from 1.21 to 30.70 over the past decade. While the company's 10-year median is 4.32 vs. the industry median of 1.67, Malaysian Genomics Resource Centre Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Diagnostics & Research company?
The median Quick Ratio among Medical Diagnostics & Research companies is 1.67, based on 215 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Malaysian Genomics Resource Centre Bhd's current Quick Ratio of 5.26 is 215% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Malaysian Genomics Resource Centre Bhd and its competitors. For the Medical Diagnostics & Research industry, the median Quick Ratio is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Malaysian Genomics Resource Centre Bhd's current Quick Ratio is 5.26, which is 22% above median its own 10-year median of 4.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Malaysian Genomics Resource Centre Bhd stock overvalued right now?
Based on GuruFocus' analysis, Malaysian Genomics Resource Centre Bhd (XKLS:0155) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.30, compared to a current price of RM0.27 — trading 10% below its estimated fair value. The current Quick Ratio is 5.26, which is 22% above median its 10-year median of 4.32 and 215% above the Medical Diagnostics & Research industry median of 1.67. Malaysian Genomics Resource Centre Bhd's overall GF Score™ is 47/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Malaysian Genomics Resource Centre Bhd (XKLS:0155), the current Quick Ratio is 5.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Malaysian Genomics Resource Centre Bhd (XKLS:0155) Overvalued in 2026?
Based on GuruFocus' analysis, Malaysian Genomics Resource Centre Bhd stock appears to be undervalued.
The current stock price of RM0.27 is trading 10% below its estimated GF Value™ of RM0.30.
GuruFocus considers Malaysian Genomics Resource Centre Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0155:
Quick Ratio: 5.26 (22% above median its 10-year median of 4.32)
GF Value™: RM0.30 vs. price of RM0.27 (10% below fair value)
Industry Position: 215% above the Medical Diagnostics & Research median (#24 of 215)
No single metric tells the full story. See the XKLS:0155 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Malaysian Genomics Resource Centre Bhd Business Description
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company. The company's principal activities include enabling personalized and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services, as well as investment holding. It offers genome sequencing and analysis (GSA) services and genetic screening services (GSS). The group offerings include precision genetic screening, project-based analysis, and high-quality cell therapy and cosmeceutical products. The reportable segments of the Group derive their revenue from the provision of personalised and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services within the healthcare segment.
47GF Score
Get the complete analysis for XKLS:0155
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0155 has been successfully added to your 
